• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PER

PERCHERON THERAPEUTICS LIMITED

0.00% ! 0.9¢
Market Cap $9.786M  !

Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a... Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a biotechnology company. The Company is engaged in developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The Company’s products include ATL1102 for Duchenne muscular dystrophy (DMD), ATL1103 for Acromegaly, and ATL1102 for Multiple Sclerosis (MS). ATL1102, is an antisense inhibitor targeting very late antigen 4 (VLA-4), an immune cell molecule. ATL1103 is a second-generation antisense drug designed to block growth hormone receptor (GHr) expression thereby reducing levels of the hormone insulin-like growth factor-I (IGF-I) in the blood and is a potential treatment for diseases associated with excessive growth hormone action. By inhibiting GHr production, ATL1103 in turn reduces IGF-I levels in the blood (serum). The Company is conducting a Phase II clinical trial of ATL1102 in DMD patients.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PER 10/09/25 39 12K
10/09/25 Last post  Motors Comments Created with Sketch.  39  Views Created with Sketch.  12K 
PER 08/09/25 7 1.7K
08/09/25 Last post  Motors Comments Created with Sketch.  7  Views Created with Sketch.  1.7K 
PER
Research report
28/08/25 30 5.5K
28/08/25 Last post  Motors Comments Created with Sketch.  30  Views Created with Sketch.  5.5K 
PER 28/08/25 0 159
28/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  159 
PER 28/08/25 0 127
28/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  127 
PER 28/08/25 0 203
28/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  203 
PER
Video on suppression of immune system checkpoints
21/08/25 4 691
21/08/25 Last post  Motors Comments Created with Sketch.  4  Views Created with Sketch.  691 
PER
per-chart
33 34 35
19/08/25 2.0K 611K
19/08/25 Last post  asx11 Comments Created with Sketch.  2.0K  Views Created with Sketch.  611K 

See All Discussions arrow Created with Sketch.

Timeline

Percheron Receives $1.43m R&D Tax Incentive Rebate
29 Aug 09:08
 
Notice of date of AGM and other relevant dates
28 Aug 13:41
 
Appendix 4G and Corporate Governance Statement
28 Aug 13:36
 
Appendix 4E and Annual Report
28 Aug 13:33
 
New Preclinical Data Reported for HMBD-002 in Breast Cancer
06 Aug 08:17
 
Quarterly Activities Report and Appendix 4C
31 Jul 08:20
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $9.786M
Open High Low Value Volume
0.9¢ 0.9¢ 0.9¢ $14.4K 1.6M

Buyers (Bids)

No. Vol. Price($)
3 912140 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 3206939 8
View Market Depth
Last trade - 12.11pm 12/09/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.